tirzepatide weight loss stories Before & After: My Honest 50 Lb Journey Tirzepatide weight loss testimony :

Despite accounting for 12.6% of global GLP-1 clinical trial activity in 2025, placing it third globally behind the US and China, prescribing rates for obesity indications remain comparatively low

This comes directly from the clinical trial design, and four weeks is generally sufficient for most people to adapt to each new dose level before moving up

Protocols do not run forever

Tirzepatide is prescription-only and is not appropriate for everyone, including patients with certain thyroid cancer histories, MEN2, pancreatitis, pregnancy, or allergy to tirzepatide

NAD has also been shown to increase energy levels, which are often depleted after surgery or injury